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ABSTRACT
Fahr syndrome is an idiopathic deposition of calcium in the basal ganglia (most commonly in the Globus pallidus) of 
the brain; other most common sites may include striatum pallidum. It can have a wide variety of presentations like 
progressive psychosis, dementia, movement disorders, gait disturbances or it can also be asymptomatic.
Department of Neuro-medicine Hyderabad admitted this 28 year old male first. And then was referred to us in the 
department of Neuro-medicine JPMC Karachi. He is a known case of epilepsy for 8 years, who now presented with the 
complaint of fever, fits, and altered sensorium for 3 days. The CT scan of his brain showed hyperdense areas, bilateral 
symmetrical extensive basal and cerebral calcifications. CSF examination of the patient showed unremarkable results. 
On further examinations, it was found he also had Rhabdomyolysis and Hypoparathyroidism.
It is unusual to have an association of Fahr syndrome with Rhabdomyolysis and Hypoparathyroidism. Our case report 
describes the unique behavior of this syndrome. 
C A S E  R E P O R T
INTRODUCTION: Fahr syndrome, as the name 
indicates, was discovered by Fahr in 1930 in a patient 
55-year-old who died after a series of tetanic seizures. 
It is also known as idiopathic calcification of basal 
ganglia or bilateral striatopallidodentate calcinosis. 
Because there are calcium deposits in the brain 
particularly in areas like basal ganglia, cerebellar 
dentate nuclei, and white matter, with later atrophy. But 
the process of calcium deposits in basal ganglia only 
was defined by Delacour in 1850 1-2.
It is a rare inherited or sporadic neurological disorder 
with prevalence of <1/1,000,000 3-5. Fewer than 200 
cases have been reported till today. It is more common 
in men (male: female ratio 2:1) 6. It is further divided 
into two types:
Primary: familial brain calcification, with no any cause 
other than genetic. It has been reported commonly 
related to chromosome 14q (IBGC1) while other loci 
are identified to be on chromosomes 2 nd 8 3-8-9.
Secondary: Brain calcification due to any metabolic, 
infective, autoimmune, and other causes.
Besides Fahr syndrome, there is also another condition 
called Fahr disease. Table 01 shows the diagnostic 
checklist and difference between the Fahr disease and 
Fahr syndrome10
Clinical presentation:
A person with Fahr syndrome can present in many 
ways. However initially, it is asymptomatic. But later in 
life, between 3rd and 6th decade, it can become 
symptomatic due to any trigger and can present with: 




• Cognitive impairment, 
• Dementia, 
• Basal ganglia movement disorders and 
• Sensory changes etc.
Diagnosis:
Although the medical imaging techniques, like 
computed tomography (CT) and magnetic resonance 
imaging (MRI), are enough to see the calcifications, but 
these are not enough to diagnose a case of Fahr’s 
syndrome. So a diagnostic criteria has been 
established.
Diagnostic criteria:
1. Bilateral calcifications of the basal ganglia or other 
areas of brain on neuroimaging (may not apply to 
patients from families with Fahr’s syndrome);
2. Progressive neurological dysfunction and/or 
psychiatric symptoms;
3. Onset between the ages of 40–50;
4. Absence of biochemical abnormalities and somatic 
states suggestive of a metabolic or mitochondrial 
disease;
5. Absence of toxic, infectious or traumatic causes of 
intracranial calcifications;
6. Positive family history of Fahr’ syndrome and/or 
proved genetic background.
If a patient meets the last criterion, the diagnosis can 
be made without the presence of one of the first two 
criteria. In cases of a negative or unknown family 
history, other five criteria must be fulfilled 11.
Case report 
Our case report is about a 28-year-old male, known 
case of epilepsy for 8 years. He presented with the 
complaint of fever for 1 week and seizure followed by 
unconsciousness for 6 days. He had tonic colonic 
seizures associated with tongue bite, urinary 
incontinence and mouth froth followed by the loss of 
consciousness. The average time duration of his 
seizures was about 15-20 minutes.  He developed 
fever in one day, which was sudden in onset, low-grade, 
continuous, and associated with rigors and chills, 
irrespective of time of occurrence. The patient also had 
a history of fracture of his right femur, secondary to a 
road traffic accident. He was diagnosed with epilepsy 8 
years ago in a local clinic with no any solid reports or 
documentation but was started on carbamazepine 
200mg OD. The patient had no history of addictions or 
allergies or blood transfusions. His family history is 
significant, his elder brother is epileptic for 5 years and 
his mother is a known diabetic for an unknown period 
of time. On examination, we found that he was vitally 
stable but he had clubbing (grade one), he looked 
mildly anemic. He had positive meningeal irritation 
signs i-e neck rigidity and kerning’s sign. His pupils 
were normal and reactive to light bilaterally. His 
Cardio-respiratory systems were unremarkable.
On Investigations, that we performed, we found that his 
Hb level was decreased to 7.9 g/dl with White cell count 
increasing to 14.5*10 9, neutrophils 87% and 
lymphocytes 10%. His serum Urea Creatinine and 
Electrolytes levels showed a decrease in potassium 
levels to 2.7mEq/L, with the marked increase in urea 
145 and creatinine 6.98, suggesting acute kidney 
Injury. His CPK levels were increased to 9520 U/L, 
suggesting the diagnosis of Rhabdomyolysis, which 
may also have played role in his Acute Kidney Injury. His 
CSF examination was unremarkable. His plain CT scan 
of the brain was performed on 25 slice Toshiba Activion 
16 CT scanner with 5.0 mm slice thickness that 
showed Bilateral Basal Ganglia calcification, as arrows 
seen in figure 1. So his clinical history, examination, 
and investigations led us to the diagnosis of Bilateral 
Basal Ganglia Calcification due to Fahr syndrome. His 
alkaline phosphatase levels were in normal range but 
his Calcium levels were decreased to 6.99 with an 
increase in phosphate levels to 8.40 and with serum 
Parathyroid Hormone levels decreased to 0.8, 
suggesting Hypocalcaemia due to Hypoparathyroidism. 
The cause of Hypoparathyroidism was not found.
Figure.1 Plain CT scans of the brain  
Discussion
Fahr syndrome, a rare case of bilateral basal ganglia 
calcification. Which may present with neurological 
clinical features like seizures, gait disturbances, 
dementia, psychosis, moment disorders, and sensory 
changes etc. Bilateral basal ganglia calcification can be 
differentiated into Fahr’s disease and Fahr’s syndrome, 
as stated above. 
Our case is diagnosed as Fahr syndrome in a 
28-year-old male known case of epilepsy for 8 years. 
He presented with the complaint of tonic colonic 
seizures and fever for 1 week, loss of consciousness for 
6 days. On history, examinations and investigations of 
the patient we found bilateral calcification of basal 
ganglia on his CT scan, giving rise to diagnosis of Fahr 
syndrome. On further evaluating the labs of the patient 
we found CPK levels raised to 9520 U/L suggesting 
Rhabdomyolysis. And we also found serum calcium 
decreased to 6.99, serum phosphate of 8.40 with 
normal alkaline phosphatase levels, but decreased 
parathyroid hormone levels t 0.8 U/L suggesting strong 
diagnosis of Hypocalcaemia secondary to 
Hypoparathyroidism. The lab results also showed 
increased urea and creatinine levels. 
As in a case report, Hypoparathyroidism, 
Hypothyroidism and Thrombocytopenia: Rare 
Constellation of Fahr’s Syndrome, published in journal 
of endocrinology and metabolism 12. It was stated that 
Fahr’s syndrome is associated with 
Hypoparathyroidism. In another study, as mentioned 
above, it was stated that Fahr’s syndrome is associated 
with multiple endocrinopathies. Our case report also 
suggests that Fahr’s syndrome is also associated with 
Rhabdomyolysis. The cause of Hypoparathyroidism and 
Rhabdomyolysis in our patient was not found. 
Conclusion
We have concluded that Fahr’s syndrome is associated 
with Rhabdomyolysis and Hypoparathyroidism. But 
since Fahr syndrome is a rare inherited disease it is 
possible to have assumption of association of 
Rhabdomyolysis and Hypoparathyroidism with Fahr 
syndrome. And thus it requires a full genetic work up to 
knowing its associations with other diseases and to 
know its treatment so that we could decrease mortality 
and morbidity in young patients like ours.
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 A diagnosis of either Fahr’s disease or Fahr’s syndrome
of the following symptoms are present: 
 should be considered if some or all
 
Consider a diagnosis of Fahr’s disease if 
•  Age of onset 40 to 60 years 
•  Evidence of coarse, progressive, bilateral,
 symmetrical basal ganglia calcification
•  Presence of genetic autosomal dominant or recessive trait 
•  Basal ganglia movement disorder 
•  Pyramidal signs 
•  Cognitive impairment 
• Gait disorder 
• Cerebellar abnormalities 
•  Speech dysfunction 
•  Psychiatric presentations 
•  Sensory changes. 
Clinical presentation:
A person with Fahr syndrome can present in many 
ways. However initially, it is asymptomatic. But later in 
life, between 3rd and 6th decade, it can become 
symptomatic due to any trigger and can present with: 




• Cognitive impairment, 
• Dementia, 
• Basal ganglia movement disorders and 
• Sensory changes etc.
Diagnosis:
Although the medical imaging techniques, like 
computed tomography (CT) and magnetic resonance 
imaging (MRI), are enough to see the calcifications, but 
these are not enough to diagnose a case of Fahr’s 
syndrome. So a diagnostic criteria has been 
established.
Diagnostic criteria:
1. Bilateral calcifications of the basal ganglia or other 
areas of brain on neuroimaging (may not apply to 
patients from families with Fahr’s syndrome);
2. Progressive neurological dysfunction and/or 
psychiatric symptoms;
3. Onset between the ages of 40–50;
4. Absence of biochemical abnormalities and somatic 
states suggestive of a metabolic or mitochondrial 
disease;
5. Absence of toxic, infectious or traumatic causes of 
intracranial calcifications;
6. Positive family history of Fahr’ syndrome and/or 
proved genetic background.
If a patient meets the last criterion, the diagnosis can 
be made without the presence of one of the first two 
criteria. In cases of a negative or unknown family 
history, other five criteria must be fulfilled 11.
Case report 
Our case report is about a 28-year-old male, known 
case of epilepsy for 8 years. He presented with the 
complaint of fever for 1 week and seizure followed by 
unconsciousness for 6 days. He had tonic colonic 
seizures associated with tongue bite, urinary 
incontinence and mouth froth followed by the loss of 
consciousness. The average time duration of his 
seizures was about 15-20 minutes.  He developed 
fever in one day, which was sudden in onset, low-grade, 
continuous, and associated with rigors and chills, 
irrespective of time of occurrence. The patient also had 
a history of fracture of his right femur, secondary to a 
road traffic accident. He was diagnosed with epilepsy 8 
years ago in a local clinic with no any solid reports or 
documentation but was started on carbamazepine 
200mg OD. The patient had no history of addictions or 
allergies or blood transfusions. His family history is 
significant, his elder brother is epileptic for 5 years and 
his mother is a known diabetic for an unknown period 
of time. On examination, we found that he was vitally 
stable but he had clubbing (grade one), he looked 
mildly anemic. He had positive meningeal irritation 
signs i-e neck rigidity and kerning’s sign. His pupils 
were normal and reactive to light bilaterally. His 
Cardio-respiratory systems were unremarkable.
On Investigations, that we performed, we found that his 
Hb level was decreased to 7.9 g/dl with White cell count 
increasing to 14.5*10 9, neutrophils 87% and 
lymphocytes 10%. His serum Urea Creatinine and 
Electrolytes levels showed a decrease in potassium 
levels to 2.7mEq/L, with the marked increase in urea 
145 and creatinine 6.98, suggesting acute kidney 
Injury. His CPK levels were increased to 9520 U/L, 
suggesting the diagnosis of Rhabdomyolysis, which 
may also have played role in his Acute Kidney Injury. His 
CSF examination was unremarkable. His plain CT scan 
of the brain was performed on 25 slice Toshiba Activion 
16 CT scanner with 5.0 mm slice thickness that 
showed Bilateral Basal Ganglia calcification, as arrows 
seen in figure 1. So his clinical history, examination, 
and investigations led us to the diagnosis of Bilateral 
Basal Ganglia Calcification due to Fahr syndrome. His 
alkaline phosphatase levels were in normal range but 
his Calcium levels were decreased to 6.99 with an 
increase in phosphate levels to 8.40 and with serum 
Parathyroid Hormone levels decreased to 0.8, 
suggesting Hypocalcaemia due to Hypoparathyroidism. 
The cause of Hypoparathyroidism was not found.
Figure.1 Plain CT scans of the brain  
Discussion
Fahr syndrome, a rare case of bilateral basal ganglia 
calcification. Which may present with neurological 
clinical features like seizures, gait disturbances, 
dementia, psychosis, moment disorders, and sensory 
changes etc. Bilateral basal ganglia calcification can be 
differentiated into Fahr’s disease and Fahr’s syndrome, 
as stated above. 
Our case is diagnosed as Fahr syndrome in a 
28-year-old male known case of epilepsy for 8 years. 
He presented with the complaint of tonic colonic 
seizures and fever for 1 week, loss of consciousness for 
6 days. On history, examinations and investigations of 
the patient we found bilateral calcification of basal 
ganglia on his CT scan, giving rise to diagnosis of Fahr 
syndrome. On further evaluating the labs of the patient 
we found CPK levels raised to 9520 U/L suggesting 
Rhabdomyolysis. And we also found serum calcium 
decreased to 6.99, serum phosphate of 8.40 with 
normal alkaline phosphatase levels, but decreased 
parathyroid hormone levels t 0.8 U/L suggesting strong 
diagnosis of Hypocalcaemia secondary to 
Hypoparathyroidism. The lab results also showed 
increased urea and creatinine levels. 
As in a case report, Hypoparathyroidism, 
Hypothyroidism and Thrombocytopenia: Rare 
Constellation of Fahr’s Syndrome, published in journal 
of endocrinology and metabolism 12. It was stated that 
Fahr’s syndrome is associated with 
Hypoparathyroidism. In another study, as mentioned 
above, it was stated that Fahr’s syndrome is associated 
with multiple endocrinopathies. Our case report also 
suggests that Fahr’s syndrome is also associated with 
Rhabdomyolysis. The cause of Hypoparathyroidism and 
Rhabdomyolysis in our patient was not found. 
Conclusion
We have concluded that Fahr’s syndrome is associated 
with Rhabdomyolysis and Hypoparathyroidism. But 
since Fahr syndrome is a rare inherited disease it is 
possible to have assumption of association of 
Rhabdomyolysis and Hypoparathyroidism with Fahr 
syndrome. And thus it requires a full genetic work up to 
knowing its associations with other diseases and to 
know its treatment so that we could decrease mortality 
and morbidity in young patients like ours.
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Consider a diagnosis of Fahr’s syndrome if 
•  Age of onset 30-40 years 
•  Evidence of symmetrical, bilateral intracranial calcification 
and 
Presence of any of the following endocrinopathies: 
•  idiopathic hypoparathyroidism 
•  secondary hypoparathyroidism 
•  pseudohypoparathyroidism 
•  pseudopseudohypoparathyroidism 
•  hyperparathyroidism 
 
or 
Presence of any of the following: 
•  brucellosis infection, intrauterine or perinatal 
•  neuroferritinopathy 
•  polycystic lipomembranous osteodysplasia with sclerosing leucoencephaloathy 
•  Cockayne syndrome 
•  Aicardi-Gouteres syndrome 
•  tuberous sclerosis 
•  mitochondrial myopathy 
•  lipoizd proteinosis 
Treatment 
If Fahr’s disease— 
• No specific remediation; only symptomatic therapies. 
 
If Fahr’s syndrome— 
• Treatment should be directed at the specific pathology, 
 with symptomatic therapy adjunctively. 
Table 01 
Clinical presentation:
A person with Fahr syndrome can present in many 
ways. However initially, it is asymptomatic. But later in 
life, between 3rd and 6th decade, it can become 
symptomatic due to any trigger and can present with: 




• Cognitive impairment, 
• Dementia, 
• Basal ganglia movement disorders and 
• Sensory changes etc.
Diagnosis:
Although the medical imaging techniques, like 
computed tomography (CT) and magnetic resonance 
imaging (MRI), are enough to see the calcifications, but 
these are not enough to diagnose a case of Fahr’s 
syndrome. So a diagnostic criteria has been 
established.
Diagnostic criteria:
1. Bilateral calcifications of the basal ganglia or other 
areas of brain on neuroimaging (may not apply to 
patients from families with Fahr’s syndrome);
2. Progressive neurological dysfunction and/or 
psychiatric symptoms;
3. Onset between the ages of 40–50;
4. Absence of biochemical abnormalities and somatic 
states suggestive of a metabolic or mitochondrial 
disease;
5. Absence of toxic, infectious or traumatic causes of 
intracranial calcifications;
6. Positive family history of Fahr’ syndrome and/or 
proved genetic background.
If a patient meets the last criterion, the diagnosis can 
be made without the presence of one of the first two 
criteria. In cases of a negative or unknown family 
history, other five criteria must be fulfilled 11.
Case report 
Our case report is about a 28-year-old male, known 
case of epilepsy for 8 years. He presented with the 
complaint of fever for 1 week and seizure followed by 
unconsciousness for 6 days. He had tonic colonic 
seizures associated with tongue bite, urinary 
incontinence and mouth froth followed by the loss of 
consciousness. The average time duration of his 
seizures was about 15-20 minutes.  He developed 
fever in one day, which was sudden in onset, low-grade, 
continuous, and associated with rigors and chills, 
irrespective of time of occurrence. The patient also had 
a history of fracture of his right femur, secondary to a 
road traffic accident. He was diagnosed with epilepsy 8 
years ago in a local clinic with no any solid reports or 
documentation but was started on carbamazepine 
200mg OD. The patient had no history of addictions or 
allergies or blood transfusions. His family history is 
significant, his elder brother is epileptic for 5 years and 
his mother is a known diabetic for an unknown period 
of time. On examination, we found that he was vitally 
stable but he had clubbing (grade one), he looked 
mildly anemic. He had positive meningeal irritation 
signs i-e neck rigidity and kerning’s sign. His pupils 
were normal and reactive to light bilaterally. His 
Cardio-respiratory systems were unremarkable.
On Investigations, that we performed, we found that his 
Hb level was decreased to 7.9 g/dl with White cell count 
increasing to 14.5*10 9, neutrophils 87% and 
lymphocytes 10%. His serum Urea Creatinine and 
Electrolytes levels showed a decrease in potassium 
levels to 2.7mEq/L, with the marked increase in urea 
145 and creatinine 6.98, suggesting acute kidney 
Injury. His CPK levels were increased to 9520 U/L, 
suggesting the diagnosis of Rhabdomyolysis, which 
may also have played role in his Acute Kidney Injury. His 
CSF examination was unremarkable. His plain CT scan 
of the brain was performed on 25 slice Toshiba Activion 
16 CT scanner with 5.0 mm slice thickness that 
showed Bilateral Basal Ganglia calcification, as arrows 
seen in figure 1. So his clinical history, examination, 
and investigations led us to the diagnosis of Bilateral 
Basal Ganglia Calcification due to Fahr syndrome. His 
alkaline phosphatase levels were in normal range but 
his Calcium levels were decreased to 6.99 with an 
increase in phosphate levels to 8.40 and with serum 
Parathyroid Hormone levels decreased to 0.8, 
suggesting Hypocalcaemia due to Hypoparathyroidism. 
The cause of Hypoparathyroidism was not found.
Figure.1 Plain CT scans of the brain  
Discussion
Fahr syndrome, a rare case of bilateral basal ganglia 
calcification. Which may present with neurological 
clinical features like seizures, gait disturbances, 
dementia, psychosis, moment disorders, and sensory 
changes etc. Bilateral basal ganglia calcification can be 
differentiated into Fahr’s disease and Fahr’s syndrome, 
as stated above. 
Our case is diagnosed as Fahr syndrome in a 
28-year-old male known case of epilepsy for 8 years. 
He presented with the complaint of tonic colonic 
seizures and fever for 1 week, loss of consciousness for 
6 days. On history, examinations and investigations of 
the patient we found bilateral calcification of basal 
ganglia on his CT scan, giving rise to diagnosis of Fahr 
syndrome. On further evaluating the labs of the patient 
we found CPK levels raised to 9520 U/L suggesting 
Rhabdomyolysis. And we also found serum calcium 
decreased to 6.99, serum phosphate of 8.40 with 
normal alkaline phosphatase levels, but decreased 
parathyroid hormone levels t 0.8 U/L suggesting strong 
diagnosis of Hypocalcaemia secondary to 
Hypoparathyroidism. The lab results also showed 
increased urea and creatinine levels. 
As in a case report, Hypoparathyroidism, 
Hypothyroidism and Thrombocytopenia: Rare 
Constellation of Fahr’s Syndrome, published in journal 
of endocrinology and metabolism 12. It was stated that 
Fahr’s syndrome is associated with 
Hypoparathyroidism. In another study, as mentioned 
above, it was stated that Fahr’s syndrome is associated 
with multiple endocrinopathies. Our case report also 
suggests that Fahr’s syndrome is also associated with 
Rhabdomyolysis. The cause of Hypoparathyroidism and 
Rhabdomyolysis in our patient was not found. 
Conclusion
We have concluded that Fahr’s syndrome is associated 
with Rhabdomyolysis and Hypoparathyroidism. But 
since Fahr syndrome is a rare inherited disease it is 
possible to have assumption of association of 
Rhabdomyolysis and Hypoparathyroidism with Fahr 
syndrome. And thus it requires a full genetic work up to 
knowing its associations with other diseases and to 
know its treatment so that we could decrease mortality 
and morbidity in young patients like ours.
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Clinical presentation:
A person with Fahr syndrome can present in many 
ways. However initially, it is asymptomatic. But later in 
life, between 3rd and 6th decade, it can become 
symptomatic due to any trigger and can present with: 




• Cognitive impairment, 
• Dementia, 
• Basal ganglia movement disorders and 
• Sensory changes etc.
Diagnosis:
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If a patient meets the last criterion, the diagnosis can 
be made without the presence of one of the first two 
criteria. In cases of a negative or unknown family 
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Case report 
Our case report is about a 28-year-old male, known 
case of epilepsy for 8 years. He presented with the 
complaint of fever for 1 week and seizure followed by 
unconsciousness for 6 days. He had tonic colonic 
seizures associated with tongue bite, urinary 
incontinence and mouth froth followed by the loss of 
consciousness. The average time duration of his 
seizures was about 15-20 minutes.  He developed 
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were normal and reactive to light bilaterally. His 
Cardio-respiratory systems were unremarkable.
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lymphocytes 10%. His serum Urea Creatinine and 
Electrolytes levels showed a decrease in potassium 
levels to 2.7mEq/L, with the marked increase in urea 
145 and creatinine 6.98, suggesting acute kidney 
Injury. His CPK levels were increased to 9520 U/L, 
suggesting the diagnosis of Rhabdomyolysis, which 
may also have played role in his Acute Kidney Injury. His 
CSF examination was unremarkable. His plain CT scan 
of the brain was performed on 25 slice Toshiba Activion 
16 CT scanner with 5.0 mm slice thickness that 
showed Bilateral Basal Ganglia calcification, as arrows 
seen in figure 1. So his clinical history, examination, 
and investigations led us to the diagnosis of Bilateral 
Basal Ganglia Calcification due to Fahr syndrome. His 
alkaline phosphatase levels were in normal range but 
his Calcium levels were decreased to 6.99 with an 
increase in phosphate levels to 8.40 and with serum 
Parathyroid Hormone levels decreased to 0.8, 
suggesting Hypocalcaemia due to Hypoparathyroidism. 
The cause of Hypoparathyroidism was not found.
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as stated above. 
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ganglia on his CT scan, giving rise to diagnosis of Fahr 
syndrome. On further evaluating the labs of the patient 
we found CPK levels raised to 9520 U/L suggesting 
Rhabdomyolysis. And we also found serum calcium 
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normal alkaline phosphatase levels, but decreased 
parathyroid hormone levels t 0.8 U/L suggesting strong 
diagnosis of Hypocalcaemia secondary to 
Hypoparathyroidism. The lab results also showed 
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Fahr’s syndrome is associated with 
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above, it was stated that Fahr’s syndrome is associated 
with multiple endocrinopathies. Our case report also 
suggests that Fahr’s syndrome is also associated with 
Rhabdomyolysis. The cause of Hypoparathyroidism and 
Rhabdomyolysis in our patient was not found. 
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We have concluded that Fahr’s syndrome is associated 
with Rhabdomyolysis and Hypoparathyroidism. But 
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possible to have assumption of association of 
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know its treatment so that we could decrease mortality 
and morbidity in young patients like ours.
3 0P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S V O L .  1 3  ( 4 )   O C T- D E C E M B E R  2 0 1 8
REFERENCES
1. Dr Bruno Di Muzio, Dr Mai-Lan Ho et al. Fahr 
s y n d r o m e . 
https://radiopaedia.org/articles/fahr-syndrome-1 
(accessed 23 july 2018).
2. Jaskirat Randhawa, M.D. MykolaOnyshchenko, M.D. 
FarayiMbuvah, M.D. Rajesh Bagai, M.D.. A Rare 
Association of Fahr’s Disease With an Autoimmune 
T r i a d . 
https://neuro.psychiatryonline.org/action/doSearch
?AllField=fahr+syndrome (accessed 23 july 
2018).
3. PrBala MANYAM. Bilateral striopallidodentate 
c a l c i n o s i s . 
https://www.orpha.net/consor/cgi-bin/OC_Exp.php
?Lng=GB&Expert=1980 (accessed 23 July 
2018).
4. Manyam BV, Walters AS, Narla KR. Bilateral 
striopallidodentate calcinosis: clinical 
characteristics of patients seen in a registry.. 
Movement Disorders: official journal of the 
movement disorder society 2001; 16(2): . 
https://www.ncbi.nlm.nih.gov/pubmed/11295778
# (accessed 23 July 2018).
5. Ellie E, Julien J, Ferrer X. Familial idiopathic 
striopallidodentate calcifications. Neurology 1989; 
39(3): . 
https://www.ncbi.nlm.nih.gov/pubmed/2927646 
(accessed 23 July 2018).
6. Geschwind DH, Loginov M, Stern JM.. Identification 
of a locus on chromosome 14q for idiopathic basal 
ganglia calcification (Fahr disease).. American 
Journal of Human Genetics 1999; 65(3): . 
https://www.ncbi.nlm.nih.gov/pubmed/10441584 
(accessed 23 July 2018).
7. Dai X, Gao Y, Xu Z, Cui X, Liu J, Li Y, Xu H, Liu M, 
Wang QK, Liu JY.. Identification of a novel genetic 
locus on chromosome 8p21.1-q11.23 for 
idiopathic basal ganglia calcification.. American 
Journal of Medical genetics. Part B, 
Neuropsychiatric genetics: the official publication 
of the international society of psychiatric genetics 
5 October 2010; 153B(7): . 
https://www.ncbi.nlm.nih.gov/pubmed/20552677 
(accessed 23 July 2018).
8. Volpato CB, De Grandi A, Buffone E, Facheris M, 
Gebert U, Schifferle G, et al. 2q37 as a 
susceptibility locus for idiopathic basal ganglia 
calcification (IBGC) in a large South Tyrolean 
family.. Journal of molecular neuroscience 2009; 
39(3): . 
https://www.ncbi.nlm.nih.gov/pubmed/19757205 
(accessed 24 July 2018).
9. ShafaqSaleem, Hafiz Muhammad Aslam, Maheen 
Anwar, Shahzad Anwar, Maria Saleem, 
AnumSaleem, et al. Fahr’s syndrome: literature 
review of current evidence. Orphanet Journal of 
rare diseases 2013; 8(): . 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38
53434/#B10 (accessed 24 July 2018).
10. Malathi Latha Perugula, MD and Steven Lippmann, 
MD. Fahr’s Disease or Fahr’s Syndrome?. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC50
22990/ (accessed 10 December 2018).
11. Krzysztof Jaworski, Maria Styczyńska, Monika 
Mandecka, Jerzy Walecki, Dariusz A. Kosior. Fahr 
Syndrome – an Important Piece of a Puzzle in the 
Differential Diagnosis of Many Diseases. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC58
94054/#cit0048 (accessed 28 December 2018).
12. Nilma Malika , Vishwanath Pattan , Qiang Nai , 
Abdalla Yousif. Hypoparathyroidism, 
Hypothyroidism and Thrombocytopenia: Rare 
Constellation of Fahr’s Syndrome. Journal of 
Endocrinology and Metabolism 2014; 4(4): . 
https://pdfs.semanticscholar.org/3612/b38002b6
edd7ea39240c f7a79c0c21b074de .pd f 
(accessed 28 December 2018).
Conflict of interest: Author declares no conflict of interest. 
Funding disclosure: Nil
Author’s contribution:
Suneel Kumar; concept, data collection, data analysis, manuscript writing, manuscript review
Ahsan Ali Gaad; data collection, data analysis, manuscript writing, manuscript review
Mohsin Irshad Abbasi; data collection, manuscript writing, manuscript review
Munir Afzal; manuscript writing, manuscript review
Dr Shahnaz Shah; data collection, data analysis, manuscript writing, manuscript review
Dr Dileep kumar; data collection, data analysis, manuscript writing, manuscript review
